Skip to main content
Clinical Trials/NCT02050984
NCT02050984
Unknown
Not Applicable

A Prospective Study on the Effects of Bariatric Surgery on Blood Pressure in Patients With Obesity and Diabetes

Zhiming Zhu1 site in 1 country40 target enrollmentJanuary 2010
ConditionsObesityDiabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
Zhiming Zhu
Enrollment
40
Locations
1
Primary Endpoint
Reduction of hypertension medication prescription
Last Updated
7 years ago

Overview

Brief Summary

Bariatric surgery is generally recommended for obese people with a body mass index (BMI) of at least 40kg/m2, and for people with BMI 35 kg/m2 and serious coexisting medical conditions such as diabetes. A variety of studies showed that it cause significant weight loss, recovery from diabetes and improvement in cardiovascular risk factors, such as blood pressure. The recent guidelines suggest that patients with a BMI of more than 30 kg/m2 with co morbidities is a candidate for bariatric surgery. However, the patients with diabetes in Chinese has lower BMI than that in west country. Therefore, this research is designed to observe whether bariatric surgery reduce blood pressure in patients with diabetes and relatively lower BMI.

Registry
clinicaltrials.gov
Start Date
January 2010
End Date
December 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Zhiming Zhu
Responsible Party
Sponsor Investigator
Principal Investigator

Zhiming Zhu

Director of the Dept. of Hypertension & Endocrinology

Third Military Medical University

Eligibility Criteria

Inclusion Criteria

  • Adults aged between 18 and 60 years old.
  • Type 2 Diabetes diagnosis defined according to WHO 2006 guideline.
  • Body mass index between 25.0 and 39.9 kg/m2.

Exclusion Criteria

  • Hypertension ≥ 180/120 mmHg;
  • Type 1 diabetes, other types of diabetes or gestational diabetes;
  • Acute complications of diabetes;
  • Cerebrovascular diseases in the last 6 months.
  • Cardiovascular diseases (myocardial infarction, angina, cardiac failure) in the last 6 months.
  • Baseline psychiatric disorders: schizophrenia, bipolar disorder, severe depression, psychosis.
  • Renal diseases: diabetic nephropathy, creatinine clearance \< 30 ml/min.
  • Advanced peripheral arterial disease
  • Atrophic gastritis
  • Alcoholism or use of illicit drugs

Outcomes

Primary Outcomes

Reduction of hypertension medication prescription

Time Frame: 12 months

Reduction of hypertension medication prescription related to the baseline hypertension treatment at 12 months after surgery.

Secondary Outcomes

  • Reduction of hypertension medication prescription(1 month to 6 months)

Study Sites (1)

Loading locations...

Similar Trials